Selective serotonin reuptake inhibitor (SSRI) antidepressants, prolactin and breast cancer

Selective serotonin reuptake inhibitor (SSRI) antidepressants, prolactin and breast cancer

Selective serotonin reuptake inhibitors (SSRIs) are a widely prescribed class of anti-depressants. Laboratory and epidemiologic evidence suggests that a prolactin-mediated mechanism secondary to increased serotonin levels at neuronal synapses could lead to a potentially carcinogenic effect of SSRIs....

Full description

Bibliographic Details
Main Authors: Janet eAshbury, Linda eLévesque, Patty eBeck, Kristan eAronson
Format: Article
Language:English
Published: Frontiers Media S.A. 2012-12-01
Series:Frontiers in Oncology
Subjects:
Prolactin
breast cancer
Antidepressants
Selective Serotonin Reuptake Inhibitors
Case-Control Studies
SSRIs
Online Access:http://journal.frontiersin.org/Journal/10.3389/fonc.2012.00177/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fonc.2012.00177/full

Similar Items